How should I evaluate and manage a 72‑year‑old man with a six‑year history of slowly progressive neurologic deficits, a traumatic‑brain‑injury‑related seizure disorder, who cannot read or write, has no identification, and lives far from any facility with magnetic resonance imaging or cerebrospinal‑fluid testing?

Management of Progressive Neurologic Deficits in a 72-Year-Old with Remote TBI and Limited Access to Advanced Imaging

Immediate Clinical Assessment Without Advanced Imaging

In this resource-limited setting with a six-year progressive decline, you must conduct a systematic bedside neurologic examination focusing on localizing signs that suggest treatable structural lesions versus diffuse neurodegenerative processes. 1

Critical Bedside Examination Elements

• Document progressive cognitive decline patterns: Memory loss, language impairment, executive dysfunction, and behavioral changes suggest chronic traumatic encephalopathy or post-TBI dementia 1, 2
• Assess for focal neurologic deficits: New weakness, sensory loss, visual field cuts, or cranial nerve abnormalities indicate structural lesions requiring urgent intervention 1
• Evaluate gait and motor function: Progressive quadriplegia or paraplegia may indicate spinal pathology or chronic subdural collections 3
• Screen for seizure characteristics: Document seizure semiology, frequency, and any changes over six years, as this guides anticonvulsant management 1, 4

Red Flags Requiring Urgent Transfer Despite Barriers

• Acute neurologic deterioration (new focal deficits, decreased consciousness, severe headache) mandates immediate transfer for CT imaging, as this indicates potentially life-threatening structural pathology 1
• Status epilepticus or uncontrolled seizures despite anticonvulsant therapy requires advanced care 3, 4
• Signs of increased intracranial pressure (papilledema, progressive headache, vomiting) suggest mass effect requiring neurosurgical evaluation 1

Empiric Management Strategy Without MRI/CSF Access

Optimize Seizure Control First

Ensure therapeutic anticonvulsant levels through careful dose titration, as uncontrolled seizures cause secondary brain injury and worsen cognitive outcomes. 4, 5

• For carbamazepine (if currently used): Titrate to 800-1200 mg daily in divided doses for adults, monitoring for clinical response 5
• Avoid medications with significant sedative or anticholinergic properties, as these worsen cognition in elderly patients with brain injury 2
• Monitor for drug-drug interactions and adjust doses empirically based on seizure control and side effects 2

Address Treatable Causes of Progressive Decline

• Trial of corticosteroids may be considered if inflammatory/autoimmune etiology is suspected (fluctuating course, multifocal deficits), though this requires careful risk-benefit assessment without tissue diagnosis 6
• Optimize blood pressure control for vascular risk reduction, as hypertension contributes to progressive white matter disease and cognitive decline 7
• Ensure adequate nutrition and metabolic supplementation, particularly B vitamins, as deficiencies exacerbate neurologic dysfunction 7

When to Pursue Transfer for Advanced Imaging

MRI becomes essential when persistent unexplained neurologic findings exist despite optimized medical management, as it detects 27-33% more abnormalities than CT and provides crucial prognostic information. 1, 8

Specific Indications for MRI (When Accessible)

• Progressive cognitive decline with focal deficits suggests structural lesions (chronic subdural hematoma, tumor, encephalomalacia) that MRI detects with superior sensitivity 1, 8
• Unexplained seizure worsening may indicate underlying lesions missed by clinical examination, as MRI identifies epileptogenic foci in 87-90% of temporal lobe epilepsy cases 1
• Chronic TBI sequelae evaluation: MRI with T2*-weighted and susceptibility-weighted imaging detects microhemorrhages and diffuse axonal injury invisible on CT (90% of cases) 1, 8

CT Limitations in This Context

CT has only 30% success in detecting focal lesions in epilepsy and cannot explain persistent neurologic deficits in chronic TBI. 1, 8

• CT is useful only for acute hemorrhage, skull fractures, and large mass lesions requiring urgent intervention 1
• Normal CT does not exclude significant brain injury, as 27% of patients show clinically relevant MRI abnormalities 8

Practical Management Algorithm for Resource-Limited Settings

Step 1: Stabilize and Optimize Current Treatment

• Maximize anticonvulsant therapy with careful dose titration 5, 4
• Control vascular risk factors (hypertension, diabetes) 7
• Provide nutritional support and metabolic supplementation 7

Step 2: Document Progression Carefully

• Use standardized scales (Barthel Index for functional status) to track decline objectively 1
• Maintain detailed seizure logs documenting frequency and semiology 1
• Monitor for new focal deficits suggesting structural lesions 1

Step 3: Identify Transfer Triggers

• Acute deterioration (decreased consciousness, new focal deficits, uncontrolled seizures) requires immediate transfer 1
• Persistent unexplained deficits despite optimized medical management warrant MRI when feasible 1, 8
• Suspected treatable structural lesions (chronic subdural, tumor, hydrocephalus) based on clinical pattern 1

Critical Pitfalls to Avoid

• Do not assume progressive decline is inevitable without excluding treatable causes like chronic subdural hematoma, normal pressure hydrocephalus, or metabolic disorders 1, 7
• Do not rely solely on clinical examination to exclude structural pathology, as MRI detects lesions in 27% of patients with normal CT and persistent symptoms 8
• Do not continue ineffective anticonvulsant regimens without dose optimization or medication changes, as uncontrolled seizures cause secondary brain injury 4
• Do not overlook systemic factors (renal disease, hypertension, nutritional deficiencies) that contribute to neurologic decline 7